Login / Signup

Clinical trials of biosimilars should become more similar.

Jonathan KayJohn D Isaacs
Published in: Annals of the rheumatic diseases (2016)
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • phase iii
  • study protocol
  • randomized controlled trial